• Dihydroartemisinin (SKU N1713): Reliable Workflows for Cell

  2026-05-15

  This article provides scenario-driven guidance for leveraging Dihydroartemisinin (SKU N1713) in cell viability, proliferation, and cytotoxicity assays. It addresses practical laboratory challenges—such as compound solubility, mTOR signaling pathway analysis, and product reliability—while synthesizing evidence-backed recommendations for biomedical researchers. The discussion highlights APExBIO’s Dihydroartemisinin as a reproducible, high-purity solution for advanced research workflows.

• Advancing Bioaerosol Detection: Removing Pollen Spectral Int

  2026-05-15

  This study introduces a robust spectral data transformation and machine learning workflow to accurately distinguish hazardous bioaerosols from pollen using excitation–emission matrix (EEM) fluorescence spectroscopy. By eliminating pollen spectral interference, the approach enhances rapid detection of pathogens and toxins, supporting public health monitoring.

• Patient-Derived Gastric Cancer Assembloids Advance Tumor Mod

  2026-05-14

  This study introduces a patient-specific gastric cancer assembloid that integrates tumor organoids with matched stromal cell subpopulations, providing a more physiologically relevant model of tumor heterogeneity and drug response. The platform allows for improved investigation of tumor–stroma interactions and supports personalized drug screening strategies.

• Atrial Natriuretic Peptide: Applied Workflows for Cardiovasc

  2026-05-14

  Discover how Atrial Natriuretic Peptide (ANP) elevates cardiovascular research with robust, reproducible protocols and advanced troubleshooting. This guide translates recent mechanistic insights and peer-reviewed workflows into actionable steps for maximizing assay integrity and data quality with APExBIO’s high-purity ANP peptide hormone.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) for Advanced mRNA Delivery

  2026-05-13

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) streamlines dual-fluorescence mRNA delivery assays, letting researchers quantify uptake and translation efficiency in real time. Its immune-evasive chemistry and robust Cap 1 structure provide a decisive edge for nanoparticle validation, gene regulation studies, and troubleshooting transfection protocols.

• Fluorouracil in Advanced Colon Cancer Research: Molecular In

  2026-05-13

  Explore the molecular mechanisms and assay optimization of Fluorouracil (5-Fluorouracil) in colon cancer research. Discover how genomic heterogeneity impacts drug response, with practical guidance for experimental design and interpretation.

• HR Pathway Profiling Predicts Olaparib Sensitivity in Mesoth

  2026-05-12

  Borchert et al. (2019) identified that gene expression profiles reflecting homologous recombination repair (HRR) deficiencies—'BRCAness'—are present in a subset of malignant pleural mesothelioma (MPM) cases, correlating with enhanced sensitivity to PARP inhibition by olaparib. Their findings point to novel stratification strategies and combinatorial chemotherapy approaches in MPM, potentially improving outcomes through precision targeting of DNA repair vulnerabilities.

• Selective FGFR1 Inhibition in Neuronal Survival: Insights fr

  2026-05-12

  This study establishes PD 173074 as a highly selective, nanomolar-potency FGFR1 inhibitor that antagonizes FGF-2-mediated neurotrophic and neurotropic effects in neurons. The findings offer a robust experimental tool for dissecting FGF signaling in neural development and disease models without off-target disruption of other neurotrophic pathways.

• Applied Workflows with Enhanced ECL Chemiluminescent Detecti

  2026-05-11

  The ECL Chemiluminescent Substrate Detection Kit (Enhanced) from APExBIO delivers unmatched sensitivity and prolonged signal for western blot chemiluminescence detection, simplifying workflows for low-abundance protein targets. This article translates cutting-edge research into actionable protocol enhancements, troubleshooting tips, and comparative insights for advanced antibody detection assays.

• Norovirus Selectively Exploits NINJ1 for Viral Protein Secre

  2026-05-11

  Song et al. reveal that murine norovirus hijacks the host protein NINJ1 to enable selective secretion of the viral NS1 protein through a non-canonical pathway. This study advances understanding of regulated cell death and viral immune evasion, highlighting mechanistic links relevant for cell biology and pathogen-host interaction research.

• Pexmetinib (ARRY-614): Enhancing Cytokine Inhibition Workflo

  2026-05-10

  Pexmetinib (ARRY-614) empowers researchers to dissect inflammatory and angiogenic pathways with dual kinase inhibition, robust cytokine suppression, and new conformational insights. This guide translates recent structural advances and best-practice protocols into actionable, reproducible results for myelodysplastic syndromes and inflammation research.

• DMH-1 Enables Precision in BMP Pathway Control for Translati

  2026-05-09

  Explore how DMH-1, a selective ALK2 inhibitor, unlocks tunable control of BMP signaling for organoid engineering and non-small cell lung cancer research. This thought-leadership article synthesizes cutting-edge mechanistic insights, recent human organoid system advances, and actionable protocol guidance for translational researchers, referencing APExBIO's DMH-1 and the latest literature.

• Octanoic Acid Nutrition Modulates IBD via PPARγ/STAT-1/STAT-

  2026-05-08

  This study demonstrates that octanoic acid-rich enteral nutrition alleviates inflammatory bowel disease by regulating intestinal macrophage polarization through the PPARγ/STAT-1/STAT-6 signaling axis. The findings highlight the mechanistic role of PPARγ in immune modulation and offer a molecular basis for nutritional interventions in IBD management.

• T-5224: Applied Workflows for C-Fos/AP-1 Inhibition in Infla

  2026-05-08

  T-5224, a selective C-Fos/AP-1 inhibitor from APExBIO, transforms arthritis and neuroinflammation research by enabling precise modulation of MMPs and pro-inflammatory cytokines. With robust in vitro and in vivo validation, it delivers reproducible results in models where AP-1 signaling drives pathology.

• Fluorouracil in Solid Tumor Research: Protocols & Optimizati

  2026-05-07

  Fluorouracil (Adrucil) from APExBIO delivers reproducible inhibition of DNA replication in solid tumor models, with validated protocols supporting colon and breast cancer research. This guide translates mechanistic insights and recent breakthroughs into stepwise workflows and troubleshooting strategies that maximize data quality and translational impact.

15071 records 1/1005 page Next 12345 下5页 Last page